Subhasmita Bhal

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

Carbon Nanotubes

Breast Cancer Cells

Top Venues

Medical oncology (Northwood, London, England)

Journal of molecular modeling

This page only lists publications with an associated author ORCID identifier.

Publications

Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Saptarshi Sinha, Subarno Paul, Sushree Subhadra Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu
Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation. Medical oncology (Northwood, London, England) 41 (2) (2024)
Chanchal Kiran Thakur, Fábio G Martins, Chandrabose Karthikeyan, Subhasmita Bhal, Chanakya Nath Kundu, N S Hari Narayana Moorthy, Sérgio F Sousa
In silico-guided discovery and in vitro validation of novel sugar-tethered lysinated carbon nanotubes for targeted drug delivery of doxorubicin. Journal of molecular modeling 30 (8) (2024)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)
Subhasmita Bhal, Chanakya Nath Kundu
Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics. Medical oncology (Northwood, London, England) 40 (2) (2023)